News Image

Emmaus Life Sciences Reports 2024 Financial Results

Provided By PR Newswire

Last update: Apr 15, 2025

TORRANCE, Calif., April 14, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2024.

Read more at prnewswire.com
Follow ChartMill for more